Submitted by Anonymous (not verified) on 19 August 2025 - 11:00
Human medicines European public assessment report (EPAR): Tyruko, natalizumab, Date of authorisation: 22/09/2023, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tyruko, natalizumab, Date of authorisation: 22/09/2023, Revision: 2, Status: Authorised